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ABSTRACT 
Objective: The objective of this study is investigating the potential of curcumin metal complexes in pharmaceutical and cosmetic products. 
Methods: Curcumin was complexed with five divalent transition metals (Zn(II), Cu(II), Fe(II), Mn(II), and Mg(II)) and then investigated for their 
anti-tyrosinase activity and their mode of inhibition against mushroom tyrosinase and cytotoxicity against KB and MCF-7 cell lines. 
Results: The tyrosinase inhibition of curcumin increased in the presence of Mn (II) and Zn (II); however, the activity was reduced after 
complexingwith Cu (II), Fe (II), and Mg (II). Curcumin manganese complex (curcumin-Mn) exhibited the highest potent anti-tyrosinase activity with 
classical noncompetitive inhibitor which showed the inhibition constant (KI)of 3.57 µg/mL(7.58µg/mL for free curcumin). For the cytotoxicity 
against KB and MCF7 cell lines, free curcumin showed cytotoxicity against both KB (IC50
Conclusion: This study suggests a potential use of the curcumin-Mn and Zn as a depigmentation agent in cosmetic products. 
 9.58 µg/mL) and MCF7 (13.86 µg/mL) cancer cell lines;   
whereas, it was found to be lower in the metal complexes. 
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INTRODUCTION 
Curcumin is a polyphenol yellow pigment found in rhizomes of 
curcuma species. It is widely used as an active substance in food 
supplements, cosmetics, and pharmaceuticalsdue to its multiple 
therapeutic activities. These include anti-cancer [1], anti-
inflammatory, anti-bacterial, anti-fungal [2], anti-oxidant [3], 
inhibition of lipid per oxidation and anti-tyrosinase [4]. Curcumin 
was used in anti-wrinkle, anti-acne, and skin whitening products. 
However, a major problem in application of this compound in 
pharmaceutical and cosmetic products is that it rapidly decomposes 
under high temperature and exposure to light [5-6].  
Several studies demonstrated that the stability and biological 
activities of curcumin can be enhanced by complexing with 
transition metal ions. Complexation of curcumin with Zn(II) and 
Mg(II) can enhanced the thermal and UV stability in solution and 
emulsion systems [7]. Lipid peroxidation and superoxide dismutase 
(SOD) activity increased six- and ten-fold, respectively, when 
curcumin was complexed with Cu (II) [8-9]. The antioxidant activities 
of curcumin complexes with Zn(II), Cu(II), Fe(II), Mg(II), and Mn(II)) 
have better DPPH radical scavenging and ferrous reducing power 
activities than free curcumin with the same dosage [10]. 
Skin whitening products are very popular, especially in Asian 
countries. These products focus on lightening skin color and treating 
the production of abnormal pigmentation such as melasma, freckles, 
agespots, liver spots, and other forms of melanin hyperpigmentation 
[11]. Depigmentation agents act at various levels of melanin 
production in the skin. Many of them are known as competitive 
inhibitors of tyrosinase, which is the key enzyme in melanogenesis. 
This enzyme is a copper-containing enzyme that catalyzes the 
production of melanin from tyrosine by oxidation reaction [12]. 
Hence, the compounds that inhibit tyrosinase activity leading to skin 
lightening have been the subject of much research [13-15]. In order 
to investigate the potential of curcumin metal complexes in 
pharmaceutical and cosmetic products, this study will evaluate anti-
tyrosinase and cytotoxicity activities of curcumin metal complexes. 
MATERIALS AND METHODS 
The chemicals and reagents were analytical grade. Curcumin, kojic 
acid, L-tyrosine and tyrosinase enzyme, zinc acetate (Zn(OAc)2), 
copper acetate (Cu(OAc)2), manganese dioxide (MnO2) and 
magnesium chloride (MgCl2)were purchased from Sigma. Ethanol, 
methanol and DMSO were purchased from Merck. Sodium 
dihydrogenphosphate (NaH2PO4•2H2O), and disodium hydrogen 
phosphate (Na2HPO4•12H2
Preparation ofcurcumin-metal complexes 
O) were purchased from Prolabo. 
Ethanolic solution of 0.1 M metal salt (5 mL) was added dropwise to 
5 mL of 0.1 M curcumin solution and reflux at 60 °C for 3 hours. 
After the reaction was complete (as assessed by the precipitate 
occurred), the solution was then cooled to room temperature and 
washed with cold ethanol-water. The precipitates were then dried, 
weighted and calculated for their yield percent. 
Determination of anti-tyrosinase activity 
Anti-tyrosinase activity of curcumin and their metal complexes was 
determined according to the method of Rangkadilok [16]. Briefly, L-
tyrosine solution (40 µl;   1.7 mM) was dissolved in phosphase buffer 
(pH 6.8; 40 µl;   0.1M) and then added to 40 µl of samples in DMSO. 
After incubation for 10 minute at room temperature, 40 µl of 
mushroom tyrosinase (245 U/mL in pH 6.5 phosphase buffer) was 
added and the mixture was then incubated for 20 minute at room 
temperature. The absorbance of the reaction was recorded at 490 
nm using microplate-reader(UVM 340, Biochrom). The percentage 
inhibition of tyrosinase was calculated by following equation 
Anti− tyrosinase activity (%) =
Abscontrol − Abssample 
Abscontrol
× 100 
Where, Abscontrol  is absorbance of control at 490 nm, Abssample
The IC
 is 
absorbance of sample at 490 nm. 
50
The metal curcumin complex with the highest anti-tyrosinase 
activitywas determined for its inhibition mechanism by using a 
Lineweaver–Burk plot compared with standard curcumin. The 
inhibition constant of complex (KI) was determined by plotting the 
intercept values versus the concentration of the corresponding 
compound. 
 values were determined from plots of percent inhibition 50 
versus inhibitor concentration and were calculated by linear 
regression analysis from the mean inhibitory values. Kojic acid was 
used as the reference tyrosinase inhibitor. All tests were performed 
in triplicate. 
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Determination of cytotoxicity 
The cytotoxicity experiments were based on resazurinmicroplate 
assay (REMA) as described by Brien [17]. Two cancer cell line 
including KB and MFC7 cancer cell lines were used. In brief, cell line 
at logarithmic growth phase were harvested and diluted to 
7x104cells/ml fresh medium. The 5µl of test sample diluted in 5% 
DMSO and 45 µl of cell suspension were successively added to a 96-
well plate and incubated at 37 °C in a 5% CO2
Where, FUT and FUC are the mean fluorescent intensity from treated 
and untreated conditions respectively.  
 incubator. After 3 days 
of incubation, 12.5 µl of 62.5 g/ml resazurin solution was added to 
each well and the plate was then incubated at 37°C for 4 hr. 
Fluorescence signals were measured using a microplate reader at 
excitation and emission wavelengths of 530 nm and 590 nm, 
respectively. Ellipticine and doxorubicin were used as positive 
controls and 0.5% DMSO as negative control. Percent inhibition of 
cell growth was calculated with the following equation.  





Data were expressed as means standard deviations (SD) of three 
replicate determinations. One way analysis of variance (ANOVA) was 
used to determine the differences among the means. P values < 0.05 
were regarded as significant.  
RESULTS AND DISCUSSIONS 
In this study, five metals including Zn, Cu, 
 
Fe, Mg, and Mn were 
chosen to complex with curcumin based on their color, toxicity, 
economic and cosmetic regulation. The complexes were successfully 
prepared by refluxing the mixture of curcumin and metal salts in 
ethanol for three hours, resulting in different colored powder (Fig. 
1). The color of all complexes was darker than that of free 
curcuminresulting from the reaction between metals and curcumin 
ligand. Zn, Mn, and Mg complexes of curcumin were light red-brown 
colorpowder, while those of Cu and Fe were a solid dark brown 
color. The yield percent was calculated based on the weight of 
complexes and decreased in order;   curcumin-Fe (87.3%) 
>curcumin-Cu (79.2%) >curcumin-Mn (75.7%) >curcumin-Zn 













Fig. 1: The physical appearance of curcumin complexes a) curcumin, b) Cur-Zn, c) Cur-Cu, d) Cur-Fe, e) Cur-Mn, f) Cur-Mg 
 
The interaction between the metal and curcumin at β-diketone 
group of the prepared complexes was confirmed by UV-vis and IR 
spectroscopic techniques[9]. In our previous study, the stability and 
antioxidant activities of curcumin-metal complexes were 
investigated and the results indicated that curcumin-Zn and 
curcumin-Mg are more stable and have a stronger antioxidant 
activity than free curcuminat the same dosage. The most powerful 
metal enhancing antioxidant ability of curcumin is Zn [10]. 
This study aimed to investigate the anti-tyrosinase activity of 
curcumin metal complexes for using as depigmentationagents in 
cosmetic products,which is of much interest to the pharmaceutical 
and cosmetic industry. The effect of curcumin metal complexes on 
tyrosinase activity was determined using the L-tyrosine oxidation 
assay. The absorbance at 490 nm decreases as a result of the 
reaction of melanin synthesis was interrupted. The activity 
expressed as IC50 values;   the concentration of sample required for 
50% inhibition of tyrosinase enzyme. Enzyme activity was directly 
related to curcumin concentration. Free curcumin showed inhibition 
of tyrosinase enzyme with IC50 31.52 µg/mL. The anti-tyrosinase 
activity of metal derivatives was in order of curcumin-
Mn>curcumin-Zn >curcumin≅kojic acid ≅curcumin-Mg >curcumin-
Cu ≅curcumin-Fe. The inhibition of tyrosinase activity of curcumin-
Mn (IC50 10.82 µg/mL) and curcumin-Zn (IC50
In order to investigate the inhibition mechanism of the complexes, 
curcumin-Mnwhich showed the highest inhibition value was 
determined by using a Lineweaver–Burk plot compared with 
standard curcumin. The inhibition mechanisms can provide a basis 
for the development of new effective tyrosinase inhibitors. True 
inhibitors are classified into four types:   competitive inhibitors, 
uncompetitive inhibitors, mixed type inhibitors, and non-
competitive inhibitors. The inhibitors that combine with free 
enzyme and then prevent substrate binding with it are known as 
competitive inhibitors. The uncompetitive inhibitors can bind to the 
enzyme-substrate complex. The mixed type inhibitors and non-
competitive inhibitors bind with both free enzyme and enzyme-
substrate complex with different equilibrium binding constants and 
with the same equilibrium binding constants, respectively (Fig. 2) [19]. 
 25.22 µg/mL) 
showed significantly higher than those of free curcumin and kojic 
acid, a commercial whitening agent. Curcumin-Mg showed the anti-
tyrosinase activity to be equally strong to free curcumin and 
standard kojic acid. In contrast, curcumin-Cu and curcumin-Fe 
showed three-fold lower tyrosinase activity than standard 
compounds. The tyrosinase inhibition activity of curcumin was 
enhanced by complexing with Mn(II) and Zn(II), but was decreased 
in the presence of Mg(II), Cu(II), and Fe(II). This may be due to the 
effects from various metals give differentplanar structureof the 
complexesleading to their different chelation patternwith the active 
site of tyrosinase enzyme [18]. 
 
 
Fig. 2: Action mechanism of reversible inhibition. Complexes 
are:   E = enzyme, S = substrate, I = inhibitor, P = product, ES = 
enzyme-substrate, EI = enzyme-inhibitor, and ESI = enzyme-
substrate-inhibitor 
 
Fig. 3 displayed as a plot of1/V versus 1/[S] gave three straight lines 
with different slopesand a horizontal line that intersected at the 
same point. With anincrease in compound concentration, the Vmax 
value decreased, whereas the Km value remained the same, 
suggesting that curcumin-Mn complex is a non-competitive inhibitor 
of tyrosinase as is free curcumin (Fig. 4). The results indicated that 
curcumin-Mn bind with tyrosinase enzyme (E) and tyrosinae-
tyrosine complex (ES) with the same equilibrium binding constants. 
The inhibition constant of curcumin-Mn was determined by plotting 
the intercept values versus the concentration of the corresponding 
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compound, as shown in Fig. 4. The inhibition constant (KI) values for 
curcumin-Mn complex and free curcumin are 3.57 and 7.58 µg/mL, 
respectively. Curcumin-Mn showed more potent in tyrosinase 
inhibition than free curcumin. The cytotoxicity of all complexes on 
two human cancer cell lines, oral cavity cancer (KB) and breast 
cancer (MCF7) was evaluated. Free curcumin had moderate 
cytotoxicity against both KB and MCF7 cancer cell lines with IC50 
9.58 and 13.86 µg/mL, respectively. On KB cancer cell line, 
curcumin-Mn and Mg showed moderated cytotoxicity with IC50 
11.58 and 10.01 µg/mL. Curcumin-Zn showed weak activity, 
beingthree-fold lower than free curcumin, with IC50 33.51 µg/mL. 
On MFC7 cancer cell line, curcumin-Zn, Mn, and Mg showed lower 
cytotoxicity than free curcumin with IC50
 
 16.73, 30.07 and 26.98 
µg/mL, respectively. All curcumin-metal complexes had lower 
cytotoxicity than free curcumin in both KB and MCF7 cancer cell 
lines. The lower cytoxicity of the metal complexes might be due to 
the lower solubility of complexes when compared with free 
curcumin. These results are in related with the report of Mutasim 
[20], where curcumin-Fe complex showed lower cytotoxic than free 
curcumin 80 fold. This result may be caused by the central carbon 
atomwith the labile hydrogen is locked and unable to produce 
oxyradicals which result in the cytotoxicity behavior. 










Kojic acid 35.15 ± 0.462 - c - 
Curcumin 31.52 ± 0.128 9.58 c 13.86 
Curcumin-Zn 25.22 ± 0.047 33.51 b 16.73 
Curcumin-Cu 99.29 ± 0.018 Inactive d Inactive 
Curcumin-Fe 116.51 ± 0.771 Inactive d Inactive 
Curcumin-Mn 10.82 ± 0.256 11.58 a 30.07 
Curcumin-Mg 33.77 ± 0.196 10.01 c 26.98 
Ellipticine - 1.08 - 
Tamoxifen - - 9.52 
1
 
Different letters in column indicate significant differences among means of treatments (P < 0.01). 
 
Fig. 3: Lineweaver–Burk plots for inhibition of curcumin on 
mushroom tyrosinase for catalysis of L-Tyrosine. Concentrations 
were 2.7, 5.4, 8.1 and 10.9 µg/mL, respectively. The inset 
represents the secondary plot of 1/Vmax versus concentration of 
curcumin to determine the inhibition constant (KI). 
 
 
Fig. 4: Lineweaver–Burk plots for inhibition of Curcumin-Mn 
complex on mushroom tyrosinase for catalysis of L-Tyrosine. 
Concentrations were 2.7, 5.4, 8.1 and 10.9µg/mL, respectively. 
The insets represent the secondary plot of 1/Vmax versus 




The study demonstrates that anti-tyrosinase activity of curcumin 
can be enhanced by complexing with Mn(II) and Zn(II), whereas the 
activity was reduced when curcumin was complexed with Cu(II), 
Fe(II), and Mg(II). The highest potential on tyrosinase inhibition was 
found in curcumin-Mn, which binds toboth free tyrosinaseenzyme 
and the tyrosinase substrate complex. However, the cytotoxicity 
against both KB and MCF7 cancer cell lines of metal curcumin 
complexes are less than free curcumin. In conclusion, this study 
demonstrates the potential anti-tyrosinase capacity of curcumin-Mn 
and Zn to be processed as a depigmentation agent for esthetics 
andtreatment of hyperpigmentation disorders. 
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